Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk. [electronic resource]
Producer: 20080626Description: 854-61 p. digitalISSN:- 1460-2105
- Aged
- Antineoplastic Agents, Hormonal -- therapeutic use
- Bone Density Conservation Agents -- therapeutic use
- Breast Neoplasms -- epidemiology
- Coronary Disease -- etiology
- Female
- Fractures, Bone -- epidemiology
- Humans
- Incidence
- Lymphatic Metastasis
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Staging
- Odds Ratio
- Osteoporosis, Postmenopausal -- complications
- Proportional Hazards Models
- Raloxifene Hydrochloride -- therapeutic use
- Risk Assessment
- Risk Factors
- Selective Estrogen Receptor Modulators -- therapeutic use
- Spine
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.